This technical report describes an approach using quality risk management (QRM) for establishing and assessing the appropriateness of data integrity controls for each manufacturing operation based on the criticality and vulnerability of the data for its intended use.
Developed by subject matter experts from global industry and regulatory agencies, TR 84 summarizes manufacturing data integrity risks and identifies best practices that can be used to develop and sustain robust documentation, as well as data integrity management procedures, systems, processes, and controls. Employing these practices will help users achieve compliance with applicable laws, regulations, and directives for pharmaceutical products such as active pharmaceutical ingredients (APIs), solid oral dosage forms, sterile injectables, biologics, and vaccines.










